Literature DB >> 11438650

c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.

S Adachi1, A J Obaya, Z Han, N Ramos-Desimone, J H Wyche, J M Sedivy.   

Abstract

The c-myc proto-oncogene encodes a transcription factor that participates in the regulation of cellular proliferation, differentiation, and apoptosis. Ectopic overexpression of c-Myc has been shown to sensitize cells to apoptosis. We report here that cells lacking c-Myc activity due to disruption of the c-myc gene by targeted homologous recombination are defective in DNA damage-initiated apoptosis in the G(2) phase of the cell cycle. The downstream effector of c-Myc is cyclin A, whose ectopic expression in c-myc(-/-) cells rescues the apoptosis defect. The kinetics of the G(2) response indicate that the induction of cyclin A and the concomitant activation of Cdk2 represent an early step during commitment to apoptosis. In contrast, expression of cyclins E and D1 does not rescue the apoptosis defect, and apoptotic processes in G(1) phase are not affected in c-myc(-/-) cells. These observations link DNA damage-induced apoptosis with cell cycle progression and implicate c-Myc in the functioning of a subset of these pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438650      PMCID: PMC87219          DOI: 10.1128/MCB.21.15.4929-4937.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

Review 1.  The many roles of c-Myc in apoptosis.

Authors:  E B Thompson
Journal:  Annu Rev Physiol       Date:  1998       Impact factor: 19.318

2.  Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities.

Authors:  K J Harvey; J F Blomquist; D S Ucker
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Isolation of temperature-sensitive mutations in the c-raf-1 catalytic domain and expression of conditionally active and dominant-defective forms of Raf-1 in cultured mammalian cells.

Authors:  K K Lu; A V Bazarov; L S Yoon; J M Sedivy
Journal:  Cell Growth Differ       Date:  1998-05

4.  Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.

Authors:  Y Wang; L Szekely; I Okan; G Klein; K G Wiman
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

5.  c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

Authors:  D Reisman; N B Elkind; B Roy; J Beamon; V Rotter
Journal:  Cell Growth Differ       Date:  1993-02

6.  Distinct apoptotic responses imparted by c-myc and max.

Authors:  C E Nesbit; S Fan; H Zhang; E V Prochownik
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

Review 7.  The molecular role of Myc in growth and transformation: recent discoveries lead to new insights.

Authors:  L M Facchini; L Z Penn
Journal:  FASEB J       Date:  1998-06       Impact factor: 5.191

8.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

Authors:  N S Gray; L Wodicka; A M Thunnissen; T C Norman; S Kwon; F H Espinoza; D O Morgan; G Barnes; S LeClerc; L Meijer; S H Kim; D J Lockhart; P G Schultz
Journal:  Science       Date:  1998-07-24       Impact factor: 47.728

9.  Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.

Authors:  B Levkau; H Koyama; E W Raines; B E Clurman; B Herren; K Orth; J M Roberts; R Ross
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Authors:  F Zindy; C M Eischen; D H Randle; T Kamijo; J L Cleveland; C J Sherr; M F Roussel
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  20 in total

1.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.

Authors:  Adam Siddiqui-Jain; Cory L Grand; David J Bearss; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  Early induction of c-Myc is associated with neuronal cell death.

Authors:  Hyun-Pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Neurosci Lett       Date:  2011-10-08       Impact factor: 3.046

3.  c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells.

Authors:  Peng Zhang; Hong Li; Mo-Li Wu; Xiao-Yan Chen; Qing-You Kong; Xiao-Wei Wang; Yuan Sun; Shu Wen; Jia Liu
Journal:  J Neurooncol       Date:  2006-05-25       Impact factor: 4.130

4.  ΔNp63α down-regulates c-Myc modulator MM1 via E3 ligase HERC3 in the regulation of cell senescence.

Authors:  Yonglong Chen; Yimin Li; Yougong Peng; Xuan Zheng; Shijie Fan; Yong Yi; Peng Zeng; Hu Chen; Han Kang; Yujun Zhang; Zhi-Xiong Xiao; Chenghua Li
Journal:  Cell Death Differ       Date:  2018-06-07       Impact factor: 15.828

5.  The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity.

Authors:  Fengmei Cui; Rong Fan; Qiu Chen; Yongming He; Man Song; Zengfu Shang; Shimeng Zhang; Wei Zhu; Jianping Cao; Hua Guan; Ping-Kun Zhou
Journal:  Mol Cell Biochem       Date:  2015-06-07       Impact factor: 3.396

6.  DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation.

Authors:  Rachel Abbotts; Michael J Topper; Christopher Biondi; Daniel Fontaine; Reena Goswami; Lora Stojanovic; Eun Yong Choi; Lena McLaughlin; Aksinija A Kogan; Limin Xia; Rena Lapidus; Javed Mahmood; Stephen B Baylin; Feyruz V Rassool
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

7.  Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity.

Authors:  Xiao-Bing Fu; Xiao-Kun Li; Tong Wang; Biao Cheng; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

8.  Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.

Authors:  Che-Jen Hsiao; Yunn-Fang Ho; John T-A Hsu; Wei-Ling Chang; Yi-Cheng Chen; Ya-Ching Shen; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

9.  Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage.

Authors:  Lina Guerra; Ami Albihn; Susanna Tronnersjö; Qinzi Yan; Riccardo Guidi; Bo Stenerlöw; Torsten Sterzenbach; Christine Josenhans; James G Fox; David B Schauer; Monica Thelestam; Lars-Gunnar Larsson; Marie Henriksson; Teresa Frisan
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.